Clifford Stocks
Gründer bei OncoResponse, Inc.
Profil
Clifford J.
Stocks is the founder of OncoResponse, Inc. (founded in 2015) where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer & Director at Theraclone Sciences, Inc. (since 2011), and also holds director positions at Sinova Pharmaceuticals, Inc., Immunogenesis, Inc., and K2 Biolabs LLC.
Mr. Stocks previously worked at ICOS Corp.
(1992-2011) as the Vice President-Business Development and at Calistoga Pharmaceuticals, Inc. as the Chief Business Officer.
He received his undergraduate degree from the University of Utah and his MBA from The University of Chicago.
Aktive Positionen von Clifford Stocks
Unternehmen | Position | Beginn |
---|---|---|
Sinova Pharmaceuticals, Inc. | Direktor/Vorstandsmitglied | 04.02.2010 |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Vorstandsvorsitzender | 06.12.2011 |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Gründer | 01.10.2015 |
K2 Biolabs LLC
K2 Biolabs LLC Miscellaneous Commercial ServicesCommercial Services K2 Biolabs LLC is an early-stage life science company that aims to develop the next generation of therapies to improve the lives of patients. The company is based in Houston, TX. K2 Biolabs was founded by Kieron Jones, Andrew L. Strong, and Kevin M. Slawin, with Kieron Jones serving as the CEO since incorporation. | Direktor/Vorstandsmitglied | - |
Immunogenesis, Inc.
Immunogenesis, Inc. Miscellaneous Commercial ServicesCommercial Services Immunogenesis, Inc. develops immunotherapeutic for cold cancers. The company was founded by Michael A. Curran in 2019 and is headquartered in Houston, TX. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Clifford Stocks
Unternehmen | Position | Ende |
---|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 18.04.2011 |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Corporate Officer/Principal | - |
Ausbildung von Clifford Stocks
University of Utah | Undergraduate Degree |
The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Theraclone Sciences, Inc.
Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Commercial Services |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Health Technology |
Sinova Pharmaceuticals, Inc. | |
OncoResponse, Inc.
OncoResponse, Inc. BiotechnologyHealth Technology OncoResponse, Inc. discovers cancer immunotherapies by interrogating the human immune system. The firm identifies elite responders to immunotherapy and screens the adaptive immune system to discover antibodies with reactivity. The company was founded by Clifford J. Stocks, Kristine Swiderek and Steven H. Gillis in 2015 and is headquartered in Seattle, WA. | Health Technology |
Immunogenesis, Inc.
Immunogenesis, Inc. Miscellaneous Commercial ServicesCommercial Services Immunogenesis, Inc. develops immunotherapeutic for cold cancers. The company was founded by Michael A. Curran in 2019 and is headquartered in Houston, TX. | Commercial Services |
K2 Biolabs LLC
K2 Biolabs LLC Miscellaneous Commercial ServicesCommercial Services K2 Biolabs LLC is an early-stage life science company that aims to develop the next generation of therapies to improve the lives of patients. The company is based in Houston, TX. K2 Biolabs was founded by Kieron Jones, Andrew L. Strong, and Kevin M. Slawin, with Kieron Jones serving as the CEO since incorporation. | Commercial Services |